Exicure, Inc. (XCUR)
XCUR Stock Price Chart
Explore Exicure, Inc. interactive price chart. Choose custom timeframes to analyze XCUR price movements and trends.
XCUR Company Profile
Discover essential business fundamentals and corporate details for Exicure, Inc. (XCUR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 May 2018
Employees
7.00
Website
https://www.exicuretx.comCEO
Andy Yoo
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
XCUR Financial Timeline
Browse a chronological timeline of Exicure, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 8 Aug 2025
EPS came in at -$0.41 .
Earnings released on 27 Jun 2025
EPS came in at -$0.45 .
Earnings released on 18 Mar 2025
EPS came in at -$3.39 .
Earnings released on 14 Nov 2024
EPS came in at -$0.57 .
Stock split effective on 28 Aug 2024
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Aug 2024
EPS came in at -$0.35 .
Earnings released on 17 Jun 2024
EPS came in at -$0.50 , while revenue for the quarter reached $500.00K .
Earnings released on 6 Jun 2024
EPS came in at -$0.68 .
Earnings released on 6 Jun 2024
EPS came in at -$0.65 , while revenue for the quarter reached $516.00K , missing expectations by -86.77%.
Earnings released on 6 Jun 2024
EPS came in at -$0.66 .
Earnings released on 16 May 2024
EPS came in at -$3.05 .
Earnings released on 27 Mar 2023
EPS came in at $20.50 surpassing the estimated -$0.95 by +2.26K%, while revenue for the quarter reached $21.77M , beating expectations by +458.31%.
Earnings released on 14 Nov 2022
EPS came in at -$5.20 falling short of the estimated -$4.50 by -15.56%, while revenue for the quarter reached $2.02M , missing expectations by -48.31%.
Earnings released on 15 Aug 2022
EPS came in at -$8.30 falling short of the estimated -$1.20 by -591.67%, while revenue for the quarter reached $2.47M , missing expectations by -39.73%.
Stock split effective on 30 Jun 2022
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 May 2022
EPS came in at -$10.51 falling short of the estimated -$2.10 by -400.48%, while revenue for the quarter reached $2.57M , missing expectations by -40.35%.
Earnings released on 25 Mar 2022
EPS came in at -$22.52 surpassing the estimated -$25.53 by +11.79%, while revenue for the quarter reached $2.12M , missing expectations by -39.49%.
Earnings released on 19 Nov 2021
EPS came in at -$40.54 falling short of the estimated -$24.02 by -68.78%, while revenue for the quarter reached -$3.68M , missing expectations by -257.81%.
Earnings released on 12 Aug 2021
EPS came in at -$24.02 falling short of the estimated -$22.52 by -6.66%, while revenue for the quarter reached $79.00K , missing expectations by -94.90%.
Earnings released on 12 May 2021
EPS came in at -$21.02 falling short of the estimated -$19.52 by -7.68%, while revenue for the quarter reached $997.00K , beating expectations by +20.00%.
Earnings released on 11 Mar 2021
EPS came in at -$22.52 falling short of the estimated -$15.02 by -49.93%, while revenue for the quarter reached $140.00K .
Earnings released on 12 Nov 2020
EPS came in at -$15.02 falling short of the estimated -$13.51 by -11.18%, while revenue for the quarter reached $2.44M , beating expectations by +12.50%.
XCUR Stock Performance
Access detailed XCUR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.